|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.899
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.898
|
|
|
|
intussusceptive angiogenesis
|
GO:0002041 |
2 |
0.812
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.809
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.787
|
Mouse |
|
|
response to growth factor
|
GO:0070848 |
198 |
0.769
|
Mouse |
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.747
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.745
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.716
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.711
|
Human |
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.691
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.679
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.668
|
Mouse |
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.658
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.645
|
|
|
|
response to fibroblast growth factor
|
GO:0071774 |
47 |
0.610
|
Mouse |
|
|
axonogenesis
|
GO:0007409 |
274 |
0.602
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.566
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.565
|
Mouse |
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.556
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.556
|
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.538
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.522
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.500
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.498
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.468
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.464
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.454
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.450
|
|
|
|
chorio allantoic fusion
|
GO:0060710 |
8 |
0.448
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.443
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.430
|
|
|
|
axon regeneration
|
GO:0031103 |
12 |
0.425
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.421
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.420
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.420
|
Human |
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.420
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.418
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.409
|
|
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.405
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.404
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.404
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.404
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.397
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.394
|
|
|
|
negative regulation of vasculature development
|
GO:1901343 |
26 |
0.387
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.385
|
Rat |
|
|
cellular response to follicle stimulating hormone stimulus
|
GO:0071372 |
1 |
0.378
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.371
|
|
|
|
positive regulation of sphingolipid biosynthetic process
|
GO:0090154 |
1 |
0.364
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.356
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.356
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.356
|
|
|
|
regulation of ceramide biosynthetic process
|
GO:2000303 |
1 |
0.352
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.350
|
|
|
|
ceramide biosynthetic process
|
GO:0046513 |
20 |
0.346
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.344
|
Human |
|
|
coagulation
|
GO:0050817 |
78 |
0.340
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.337
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.326
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.324
|
|
|
|
regulation of blood vessel endothelial cell migration
|
GO:0043535 |
12 |
0.320
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.314
|
Mouse |
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.312
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.306
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity involved in g2 m transition of mitotic cell cycle
|
GO:0031660 |
1 |
0.303
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.302
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.301
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.298
|
Human |
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.291
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.289
|
|
|
|
labyrinthine layer morphogenesis
|
GO:0060713 |
21 |
0.275
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.270
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.268
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.265
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.263
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.260
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.254
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.253
|
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.253
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.247
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.246
|
|
|
|
positive regulation of nuclear transcribed mrna poly a tail shortening
|
GO:0060213 |
4 |
0.245
|
|
|
|
nerve development
|
GO:0021675 |
67 |
0.244
|
|
|
|
cellular response to gamma radiation
|
GO:0071480 |
4 |
0.240
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.237
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.230
|
|
|
|
long term synaptic potentiation
|
GO:0060291 |
25 |
0.230
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
35 |
0.228
|
|
|
|
cell adhesion mediated by integrin
|
GO:0033627 |
18 |
0.224
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.223
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.221
|
Human |
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.220
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.219
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.217
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.215
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.215
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.214
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.214
|
|
|
|
response to interleukin 1
|
GO:0070555 |
11 |
0.212
|
|
|
|
positive regulation of mrna 3 end processing
|
GO:0031442 |
5 |
0.210
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.202
|
|
|
|
regulation of ovulation
|
GO:0060278 |
3 |
0.197
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.191
|
Mouse |
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.189
|
|
|
|
substrate dependent cell migration cell attachment to substrate
|
GO:0006931 |
2 |
0.184
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
47 |
0.181
|
Mouse |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.181
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.181
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.180
|
|
|
|
regulation of endothelial cell migration
|
GO:0010594 |
22 |
0.175
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.174
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.173
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.169
|
Human |
|
|
axon guidance
|
GO:0007411 |
141 |
0.168
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.167
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.166
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.165
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.163
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.162
|
|
|
|
vitellogenesis
|
GO:0007296 |
2 |
0.162
|
|
|
|
integrin mediated signaling pathway
|
GO:0007229 |
27 |
0.160
|
Mouse |
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.160
|
Mouse |
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.159
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.159
|
|
|
|
positive regulation of osteoclast differentiation
|
GO:0045672 |
15 |
0.159
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.159
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.157
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.157
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.157
|
|
|
|
regulation of cell adhesion mediated by integrin
|
GO:0033628 |
13 |
0.155
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.154
|
|
|
|
regulation of histone modification
|
GO:0031056 |
56 |
0.153
|
|
|
|
jnk cascade
|
GO:0007254 |
72 |
0.152
|
|
|
|
macromolecule deacylation
|
GO:0098732 |
37 |
0.152
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.149
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.148
|
|
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.148
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.146
|
Mouse |
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.146
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.145
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.145
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.145
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.145
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.145
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.144
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.142
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.138
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.137
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.136
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.135
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.133
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.133
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.131
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.128
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.125
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.124
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.124
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.124
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.121
|
Human |
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
20 |
0.117
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.116
|
Mouse |
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.116
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.116
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.115
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.115
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.115
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.114
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.113
|
|
|
|
positive regulation of epithelial cell migration
|
GO:0010634 |
19 |
0.113
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.112
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.111
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.111
|
|
|
|
neuron projection regeneration
|
GO:0031102 |
14 |
0.110
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.110
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.110
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.109
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.109
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.108
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.108
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.108
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.107
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.107
|
|
|
|
forebrain cell migration
|
GO:0021885 |
58 |
0.106
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.105
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.105
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.104
|
|
|
|
protein deacetylation
|
GO:0006476 |
32 |
0.104
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.104
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.103
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
80 |
0.103
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.102
|
|
|
|
negative regulation of neuron projection regeneration
|
GO:0070571 |
3 |
0.101
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.101
|
|
|
|
learning
|
GO:0007612 |
98 |
0.100
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.100
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.099
|
|
|
|
embryonic process involved in female pregnancy
|
GO:0060136 |
7 |
0.099
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.099
|
|
|
|
response to organophosphorus
|
GO:0046683 |
22 |
0.099
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.098
|
|
|
|
positive regulation of cardiac muscle contraction
|
GO:0060452 |
2 |
0.098
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.098
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.098
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.098
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.098
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.097
|
|
|
|
negative regulation of smooth muscle cell migration
|
GO:0014912 |
2 |
0.096
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.096
|
|
|
|
substrate dependent cell migration
|
GO:0006929 |
18 |
0.095
|
|
|
|
negative regulation of ovulation
|
GO:0060280 |
1 |
0.094
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.093
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.093
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.093
|
|
|
|
apoptotic process involved in development
|
GO:1902742 |
28 |
0.093
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.093
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.093
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.093
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.092
|
Mouse |
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.091
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.091
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
81 |
0.090
|
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.090
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.090
|
Mouse |
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.089
|
|
|
|
regulation of endothelial cell proliferation
|
GO:0001936 |
23 |
0.088
|
|
|
|
central nervous system neuron development
|
GO:0021954 |
67 |
0.088
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.088
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.087
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.086
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.086
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.085
|
Mouse |
|
|
neuron death
|
GO:0070997 |
154 |
0.085
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.085
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.085
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.084
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.083
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
16 |
0.081
|
|
|
|
metanephric glomerular mesangium development
|
GO:0072223 |
3 |
0.081
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.081
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.079
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.078
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.078
|
|
|
|
positive regulation of endothelial cell migration
|
GO:0010595 |
12 |
0.076
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.076
|
|
|
|
positive regulation of myeloid leukocyte differentiation
|
GO:0002763 |
26 |
0.075
|
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.075
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.075
|
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.075
|
|
|
|
telencephalon cell migration
|
GO:0022029 |
55 |
0.074
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.074
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.073
|
|
|
|
negative regulation of neuron death
|
GO:1901215 |
98 |
0.073
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.073
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.073
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.072
|
Mouse |
|
|
cartilage development
|
GO:0051216 |
140 |
0.072
|
|
|
|
positive regulation of transforming growth factor beta2 production
|
GO:0032915 |
2 |
0.072
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.071
|
|
|
|
response to follicle stimulating hormone
|
GO:0032354 |
1 |
0.071
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.070
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.070
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.069
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.069
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.068
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.068
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.067
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.067
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.067
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.067
|
|
|
|
collagen biosynthetic process
|
GO:0032964 |
7 |
0.066
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.066
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.066
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.066
|
|
|
|
response to camp
|
GO:0051591 |
14 |
0.065
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.065
|
|
|
|
glomerulus development
|
GO:0032835 |
40 |
0.064
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.064
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.064
|
|
|
|
negative regulation of protein kinase activity by regulation of protein phosphorylation
|
GO:0044387 |
2 |
0.064
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.064
|
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.064
|
|
|
|
decidualization
|
GO:0046697 |
10 |
0.064
|
|
|
|
metanephric glomerular mesangial cell proliferation involved in metanephros development
|
GO:0072262 |
3 |
0.064
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.063
|
|
|
|
negative regulation of angiogenesis
|
GO:0016525 |
25 |
0.063
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.062
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.062
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.061
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.061
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.061
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.061
|
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.060
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
44 |
0.060
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.059
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.059
|
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.058
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.058
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.058
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.058
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.058
|
|
|
|
endothelial cell proliferation
|
GO:0001935 |
27 |
0.058
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.058
|
|
|
|
regulation of protein deacetylation
|
GO:0090311 |
17 |
0.058
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.058
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.057
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.057
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.057
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.057
|
|
|
|
ventricular septum development
|
GO:0003281 |
42 |
0.057
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.057
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.057
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.056
|
Human |
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.056
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.056
|
Human |
|
|
response to mineralocorticoid
|
GO:0051385 |
1 |
0.055
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.055
|
|
|
|
regulation of antimicrobial humoral response
|
GO:0002759 |
3 |
0.055
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.055
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.055
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.055
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.055
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.055
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.055
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.055
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.054
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.054
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.054
|
|
|
|
positive regulation of muscle contraction
|
GO:0045933 |
10 |
0.054
|
|
|
|
chondroblast differentiation
|
GO:0060591 |
2 |
0.054
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.054
|
|
|
|
regulation of synaptic transmission glutamatergic
|
GO:0051966 |
19 |
0.054
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter in response to stress
|
GO:0097201 |
1 |
0.054
|
|
|
|
negative regulation of stem cell differentiation
|
GO:2000737 |
14 |
0.053
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.053
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.053
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.053
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.053
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.053
|
|
|
|
lens morphogenesis in camera type eye
|
GO:0002089 |
24 |
0.053
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.053
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.053
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.053
|
|
|
|
regulation of multicellular organismal metabolic process
|
GO:0044246 |
14 |
0.053
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.052
|
|
|
|
glomerular visceral epithelial cell differentiation
|
GO:0072112 |
10 |
0.052
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.052
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.052
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.052
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.051
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.051
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.051
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
48 |
0.051
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.050
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.050
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.050
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.050
|
|
|
|
central nervous system projection neuron axonogenesis
|
GO:0021952 |
21 |
0.050
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.049
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.049
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.049
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.049
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.049
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.049
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.049
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.048
|
|
|
|
protein deacylation
|
GO:0035601 |
36 |
0.048
|
|
|
|
regulation of vascular wound healing
|
GO:0061043 |
2 |
0.047
|
|
|
|
elastic fiber assembly
|
GO:0048251 |
4 |
0.047
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
34 |
0.047
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
35 |
0.047
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.047
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.047
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.046
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.046
|
|
|
|
positive regulation of histone deacetylation
|
GO:0031065 |
7 |
0.046
|
|
|
|
histone deacetylation
|
GO:0016575 |
26 |
0.046
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.046
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.045
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.045
|
|
|
|
negative regulation of cell substrate adhesion
|
GO:0010812 |
16 |
0.045
|
|
|
|
positive regulation of myeloid cell differentiation
|
GO:0045639 |
43 |
0.045
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.045
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.045
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.044
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.044
|
|
|
|
positive regulation of nuclear transcribed mrna catabolic process deadenylation dependent decay
|
GO:1900153 |
5 |
0.044
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.044
|
|
|
|
negative regulation of cell adhesion mediated by integrin
|
GO:0033629 |
2 |
0.044
|
|
|
|
synaptic transmission glutamatergic
|
GO:0035249 |
36 |
0.044
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.044
|
|
|
|
positive regulation of histone modification
|
GO:0031058 |
28 |
0.043
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.043
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.043
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.043
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.043
|
Human |
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.043
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
17 |
0.043
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.043
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.043
|
|
|
|
lamellipodium organization
|
GO:0097581 |
29 |
0.043
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.042
|
|
|
|
regulation of histone deacetylation
|
GO:0031063 |
12 |
0.042
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.042
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.042
|
Human |
|
|
stress activated mapk cascade
|
GO:0051403 |
80 |
0.042
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.042
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.041
|
|
|
|
regulation of smad protein import into nucleus
|
GO:0060390 |
3 |
0.041
|
|
|
|
single organism reproductive behavior
|
GO:0044704 |
3 |
0.041
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.041
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.041
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.041
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.041
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
57 |
0.040
|
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.040
|
|
|
|
regulation of stress activated mapk cascade
|
GO:0032872 |
69 |
0.040
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.040
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.040
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.040
|
|
|
|
innervation
|
GO:0060384 |
22 |
0.040
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.040
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.040
|
|
|
|
heart valve morphogenesis
|
GO:0003179 |
21 |
0.040
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.040
|
|
|
|
kidney vasculature development
|
GO:0061440 |
15 |
0.040
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.039
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.039
|
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.039
|
|
|
|
adherens junction organization
|
GO:0034332 |
28 |
0.039
|
|
|
|
atrial septum development
|
GO:0003283 |
12 |
0.039
|
|
|
|
atrioventricular valve morphogenesis
|
GO:0003181 |
13 |
0.039
|
|
|
|
cardiac septum morphogenesis
|
GO:0060411 |
46 |
0.039
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.038
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.038
|
|
|
|
regulation of endothelial cell chemotaxis
|
GO:2001026 |
1 |
0.038
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.038
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.038
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.038
|
|
|
|
regulation of brown fat cell differentiation
|
GO:0090335 |
5 |
0.038
|
|
|
|
ovulation
|
GO:0030728 |
15 |
0.038
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.038
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.038
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.038
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.038
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.038
|
|
|
|
chronological cell aging
|
GO:0001300 |
1 |
0.038
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.038
|
|
|
|
cell migration involved in sprouting angiogenesis
|
GO:0002042 |
9 |
0.037
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.037
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.037
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.037
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.037
|
|
|
|
response to drug
|
GO:0042493 |
75 |
0.037
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.037
|
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.036
|
|
|
|
general adaptation syndrome
|
GO:0051866 |
2 |
0.036
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.036
|
|
|
|
mesenchymal cell apoptotic process involved in metanephros development
|
GO:1900200 |
4 |
0.036
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.036
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.036
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.036
|
|
|
|
associative learning
|
GO:0008306 |
61 |
0.035
|
|
|
|
positive regulation of chromosome organization
|
GO:2001252 |
33 |
0.035
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.035
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.035
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.035
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.035
|
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.035
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.035
|
|
|
|
hippo signaling
|
GO:0035329 |
11 |
0.035
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.035
|
Mouse |
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.035
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.035
|
|
|
|
cell substrate junction assembly
|
GO:0007044 |
24 |
0.034
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.034
|
|
|
|
insemination
|
GO:0007320 |
6 |
0.034
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.034
|
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.034
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
25 |
0.034
|
|
|
|
regulation of transcription from rna polymerase ii promoter in response to hypoxia
|
GO:0061418 |
2 |
0.034
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.034
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
36 |
0.034
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.034
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.034
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.034
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.033
|
|